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Raynaud’s Phenomenon
Sarah Hentemann, RN, BSN
Otterbein University, Westerville, Ohio
Introduction
Raynaud’s phenomenon (RP) is a
widely prevalent clinical disorder
commonly seen in outpatient settings. It
is characterized by episodic vasospastic
attacks of the digital arteries and
arterioles that limit blood flow to the
extremities, causing severe pain.
Temperature changes and stress are the
primary triggers that exacerbate this
disease. The classic biphasic color
changes of RP are pallor, cyanosis, and
erythema and commonly affect the
fingers and toes and more rarely, the
nose, nipples, ears, lips, and penis. RP is
divided into subcategories. Primary
Raynaud’s phenomenon (PRP) is when
no underlying medical disease exists and
the condition happens spontaneously. It
is usually benign with mild attacks and
treated with conservative measures.
Secondary Raynaud’s phenomenon
(SRP) occurs in the context of an
underlying systemic disease such as
Scleroderma (Brown, 2012, p. 41). SRP
patients often experience more severe
attacks and require pharmacological
treatments along with conservative
measures. They are at greater risk of
developing more severe symptoms such
as digital ulcerations and gangrene
(Parker, 2013, p. 23).
An increased understanding of the
pathophysiology of PRP and SRP has
enhanced the treatment options
available for these patients. Although RP
can poses problematic, debilitating
symptoms for patients, healthcare
professionals can help these patients
learn how to self-manage their disease
and live a more comfortable lifestyle.
This topic was chosen to research to
increase nurses’ knowledge of the
pathophysiology of PRP and SRP, the
presentation of the disease symptoms,
and the implications that the care
provided can have on patient outcomes.

Epidemiology
RP occurs more frequently in woman than in men with an onset median age of 14
and 27% of people presenting with the disease for the first time are 40 years or older
(Brown, 2012, p. 42). The majority of women have PRP (85%) while 15% have SRP,
whereas in men the incidence of the two types are equal (Brown, 2012, p. 42).
Worldwide, the incidence of RP in adults is 4% to 20% and about 5% to 10% of all
Americans (Vacca, 2014, p. 58). Non-modifiable risk factors associated with RP include
being a female gender and having a family history of the disease. Modifiable risk
factors include occupational use of vibrating tools, taking medications such as beta
blockers or amphetamines, smoking, and underlying conditions such as
atherosclerosis, hypothyroidism, polycythemia, and other hyperviscosity states.

Signs and Symptoms

Although the pathophysiology of RP is still being explored, much has been
uncovered from extensive research. The main concept is impaired perfusion to the
peripheral parts of extremities triggered by cold temperatures and emotional
stressors which in turn causes reversible, vasospastic attacks. In both forms of RP,
the triggers lead to vasoconstriction and vasospasms. Clinically, first the affected
digits become white (pallor) due to the decrease in blood flow and then progress to
a blue (cyanotic) color due to deoxygenation and finally turn a flushed red
(erythema) color to represent reperfusion to the affected digit after rewarming
interventions have been successful (Polidoro et al., 2012, p. 532). PRP manifests
with symmetric symptoms, usually a milder form in which the thumb is not affected
whereas SRP may have unilateral symptoms with more severe, debilitating
complications such as digital ulcerations. When the thumb is affected, this indicates
SRP and that an underlying connective tissue disease is probable. The following
table displays the important distinctions between PRP and SRP (Devulder et al.,
2011, p. 485).

The signs and symptoms of RP depend on the severity and frequency of the
vasospastic attacks. Symptoms associated with this disease include the following:
•
•
•

Numbness
Pain
Paraesthesia

Cold temperatures or emotional stressors trigger an attack and the blood supply
to the body’s extremities is temporarily ceased due to vasoconstriction, causing pain
and numbness (Mawdsley, 2011, p. 130). Paraesthesia occurs when the blood flow is
restored to these extremities. The following signs are associated with this disease
are known as the classic biphasic color changes.




Pallor (white)
Cyanosis (blue)
Erythema (red)

First, a whitening (pallor) of the extremities affected (usually the fingers or toes)
occurs due to ischemia from vasoconstriction, followed by a blue (cyanosis) color
due to the lack of oxygen, and resolving with a red (erythema) flushed color
representing reperfusion to the digits affected. Signs and symptoms usually resolve
within one hour if appropriate interventions are utilized. Other symptoms
associated more commonly with SRP are digital ulcerations, gangrene, skin thinning,
tightening, sclerodactyly, and telangiectasias (Valdovinos & Landry, 2014, p.242).
The figure below shows the classic biphasic color changes associated with RP (“Cold
fingers,” 2009, p. 4).

Implications for Nursing Care

Underlying Pathophysiology

During an episode there is sustained vasoconstriction with impaired
vasodilation, endothelial dysfunction, and platelet activation and aggregation (Vacca,
2014, p. 58). Vasoconstriction occurs as a response to triggers in the small muscular
arteries and arterioles in the digits affected. PRP is thought to be related to
abnormal vasoconstriction of digital arteries and cutaneous arterioles due to a local
functional defects in normal vascular responses. Evidence suggest that the defect is
an increase in alpha-2 adrenergic responses in the digital and cutaneous vessels that
causes arterial vasoconstriction which leads to vasospasms (Vacca, 2014, p. 58).
Capillary damage prevents the endothelium from releasing vasodilating substances
such as nitric oxide, prostaglandins, and neuropeptides, which further sustains
vasoconstriction (Vacca, 2014, p. 58). Nitric Oxide inhibits vascular smooth muscle
contraction, platelet aggregation and adhesions of platelets. With the impaired
release of nitric oxide and other vasodilating substance, vasoconstriction and
vasospasm persist. Furthermore, platelet activation and aggregation causes
endothelial cell dysfunction and activates the release of endogenous
vasoconstrictors, thus continuing to lead to sustained vasoconstriction and
vasospasms (Polidoro et al., 2012, p. 532).
The underlying disease associated with SRP is thought to disrupt the normal
mechanisms responsible for the control of vessel reactivity. Structural vascular
changes occur with SRP. The arterial lumen narrows due to adventitial fibrosis,
intimal proliferation and fibrosis, causing more severe symptoms which can lead to
tissue ischemia (Sinnathurai & Schrieber, 2013, p. 478). Recurrent episodes of
ischemia and reperfusion from SRP can lead to significant complications and
morbidity.

Significance of Pathophysiology

Those patients suffering from RP may have a diminished quality of life due to
their signs and symptoms from the disease. They can also be at high risk for
developing life-altering complications, especially those with SRP. The primary
goals of therapy are to improve the quality of life of patients, reduce the
frequency and intensity of vasospastic attacks, and to prevent ischemic tissue
injury. Understanding the mechanisms involved in the pathophysiology of this
disease process is the key to providing goal directed therapy and will allow
healthcare professionals to better educate their patients while providing them
with a better quality of life.

Advanced practice nurses (APN) must complete a full thorough history and
physical exam to diagnose RP and must be able to differentiate between PRP and
SRP. A careful history should include the age of onset, affected digits, and degree of
severity, frequency, and symmetry of attacks. The following three screening
questions should be asked to all patients with suspected RP (Wigley, 2015, p.12):
•
•
•

Are your fingers usually sensitive to cold?
Do your fingers change color when they are exposed to cold temperatures?
Do your fingers turn white, blue, or both?

If the patient has positive answers to all three questions then a diagnosis of RP
is usually made but then the APN has to inspect deeper to figure out the cause. The
APN should ask the patient about potential exposures or aggravating factors such as
occupational risks (frostbite, hand-arm vibration), medications (nicotine, nonselective beta-blockers), and neurological conditions (carpal tunnel syndrome). A
complete physical assessment should be conducted to evaluate for other symptoms
of a suggestive autoimmune disease such as fever, skin rashes, and
cardiopulmonary and musculoskeletal abnormalities. The fingers and toes should
especially be inspected for signs of tissue ischemia, as these are the most common
digits affected. Lastly, nailfold capillaroscopy is a preferred method to distinguish
between PRP and SRP. Patients with normal capillary loops around the nail bed
have PRP whereas the capillary loops around the nails bed in SRP can be enlarged,
disorganized, and may even hemorrhage (Brown, 2012, p. 42).
Once the diagnosis of RP has been made, either PRP or SRP, the APN must
determine the severity of the disease process. It is vital to have a definitive
diagnosis so that proper treatment measures can be effective. The APN must direct
nursing care at preventing complications and improving the quality of life for their
patients. The following are common conservative measures to prevent attacks:
•
•
•
•
•
•
•

Avoid cold exposure
Avoid rapidly changing temperatures
Use strategies to keep the entire body warm
Avoid cigarette smoke
Exercise
Manage stress with relaxation techniques and meditation
Have knowledge on methods to help terminate an attack

Encouraging patients to develop self-management strategies helps patients
establish a sense of empowerment. An important aspect of the management for RP
is recognizing triggers and knowing how to prevent exacerbations. APNs need to
provide support for their patients as they will be making lifestyle changes. Having a
compassionate and caring healthcare team influences the patient to make healthy
lifestyle changes and promotes a better well-being while decreasing stress.

Conclusion
RP is an exaggerated vascular response to cold temperatures or to emotional
stress, which is characterized by the classic biphasic color changes, pallor, cyanosis,
and erythema, in affected digits. In PRP, symptoms occur without an underlying
disease and treatment is focused more on conservative measures due to milder
attacks. SRP occurs in association with another disease such as an autoimmune
disease and symptoms are more severe usually requiring conservative and
pharmacological treatments. Understanding the pathophysiology of this disease
process will help APNs diagnosis this phenomenon more definitively and better
direct treatment goals to improving ones quality of life.
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